Innovent Biologics Inc. has entered into a collaboration and exclusive license agreement with F. Hoffmann-La Roche Ltd. to advance the development of IBI-3009, a novel DLL3-targeted antibody-drug ...
SAN JOSE, Calif.-- December 10, 2024 -- Rambus Inc., a premier chip and silicon IP provider making data faster and safer, today announced it has extended the term of its comprehensive patent license ...